409 related articles for article (PubMed ID: 24148254)
1. FGFR signalling in women's cancers.
Fearon AE; Gould CR; Grose RP
Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
3. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
[TBL] [Abstract][Full Text] [Related]
4. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.
Piasecka D; Braun M; Kitowska K; Mieczkowski K; Kordek R; Sadej R; Romanska H
J Exp Clin Cancer Res; 2019 May; 38(1):230. PubMed ID: 31142340
[TBL] [Abstract][Full Text] [Related]
5. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
Harmer NJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
[TBL] [Abstract][Full Text] [Related]
7. De-regulated FGF receptors as therapeutic targets in cancer.
Knights V; Cook SJ
Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factors and their receptors in cancer.
Wesche J; Haglund K; Haugsten EM
Biochem J; 2011 Jul; 437(2):199-213. PubMed ID: 21711248
[TBL] [Abstract][Full Text] [Related]
9. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
Carter EP; Fearon AE; Grose RP
Trends Cell Biol; 2015 Apr; 25(4):221-33. PubMed ID: 25467007
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic migration of mesencephalic neural crest cells in the mouse.
Kubota Y; Ito K
Dev Dyn; 2000 Feb; 217(2):170-9. PubMed ID: 10706141
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
12. Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
Sogos V; Balaci L; Ennas MG; Dell'era P; Presta M; Gremo F
Dev Dyn; 1998 Apr; 211(4):362-73. PubMed ID: 9566955
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.
Liu G; Chen T; Ding Z; Wang Y; Wei Y; Wei X
Cell Prolif; 2021 Apr; 54(4):e13009. PubMed ID: 33655556
[TBL] [Abstract][Full Text] [Related]
14. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
15. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
Flippot R; Kone M; Magné N; Vignot S
Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
[TBL] [Abstract][Full Text] [Related]
16. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
St Bernard R; Zheng L; Liu W; Winer D; Asa SL; Ezzat S
Endocrinology; 2005 Mar; 146(3):1145-53. PubMed ID: 15564323
[TBL] [Abstract][Full Text] [Related]
18. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
19. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
[TBL] [Abstract][Full Text] [Related]
20. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
Aviezer D; Safran M; Yayon A
Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
